ACRIN Abdominal Committee ACRIN Gynecologic Committee Fall Meeting 2010 Susanna I Lee, MD, PhD, Chair Massachusetts General Hospital.

Slides:

Advertisements

Similar presentations

Eric Pujade-Lauraine Hôpitaux Universitaires Paris Centre Site Hôtel-Dieu, Paris, France Ve spolupráci je síla.

Advertisements

Intraperitoneal therapy in ovarian cancer Edward L. Trimble, MD, MPH National Cancer Institute, USA.

Role of the Statistician and the Bioinformatics Scientist in Cancer Clinical Trials Larry Rubinstein, PhD Biometric Research Branch, NCI International.

PLENARY SESSION Fall Group Meeting Miami, FL November 13, 2010.

Pelvic Anatomy from the Laparoscopic Perspective

Randomized Phase III Trials of Intravenous vs. Intraperitoneal Therapy in Optimal Ovarian Cancer Deborah K. Armstrong, M.D. Associate Professor of Oncology,

Michael Birrer, PI, Director, Gynecologic Medical Oncology, MGH Lari Wenzel, Co-PI, Prof. of Medicine, University of California, Irvine

ACRIN Breast Committee October 1, 2010 Constance Lehman, M.D., PhD, FACR Professor and Vice Chair of Radiology University of Washington ACRIN Breast Committee.

The Promise of Immunotherapy for Cancer Treatment

ACRIN Abdominal Committee ACRIN Gynecologic Committee Fall Meeting 2010.

ACRIN Research Associates Educational Session Radiation Therapy Oncology Group Research Associates Committee Joyce Neading, RHIT, CTR Program Director,

1 March 2003 ODAC: DOXIL ®, Ovarian Cancer ODAC Discussion on Accelerated Approval March 12-13, 2003 DOXIL ® (doxorubicin HCl liposome injection) Treatment.

ACRIN 6671/GOG 0233 Consent for Research Study A study for Women with Advanced Cervical Cancer: Learning whether a PET/CT scan using an imaging agent called.

Annual Meeting 2011 Clinical Trial Development Clinical Trial Development: OEWG, RA’s Role, and Activating Trials on Deadline Martha Heckel Protocol Associate.

1 Targeted Strategies to Improve Physician and Patient Access to Cancer Clinical Research An Overview of Coalition Programs and Services Ruth Lambersky.

ACRIN Annual Meeting 2010 Mitchell Schnall MD, PhD Professor of Radiology University of Pennsylvania ACRIN Network Chair State of ACRIN : Working to secure.

ACRIN BDMC Fall 2011 Biostatistics and Data Management Center Constantine Gatsonis, PhD Department of Biostatistics Center for Statistical Sciences Brown.

Developing Relationships: Cooperative Group Networking Developing Relationships: Cooperative Group Networking Kandie Dempsey, MS, RN, OCN, CCRP Delaware.

Imaging Questions in Ovarian Cancer Susanna I. Lee, MD, PhD.

ACRIN Fall Meeting 2008 Mitchell Schnall MD, PhD Professor of Radiology University of Pennsylvania ACRIN Network Chair State of ACRIN : 10 years of investment.

The Quantitative Imaging Network (QIN) Robert Nordstrom, Ph.D. Larry Clarke, Ph.D.

2011 ACRIN Annual Meeting The ACRIN Accrual Project at University of Washington Constance Lehman, MD. PhD David Mankoff, MD. PhD Tiffany Wong, MS.

State of ACRIN : Extending our reach

Overview of NCI Supported Fatigue Trials Ann O’Mara, PhD, RN, FAAN.

Targeting HER2 and Focusing on Patients With Gastric Cancer Jose Maria Vieitez, MD, PhD Assistant Professor of Oncology Department of Medical Oncology.

NCI-Sponsored Clinical Trials Andrea Denicoff, RN, MS, ANP 1 Worta McCaskill-Stevens, MD 2 Jo Anne Zujewski, MD 1 Jeff Abrams, MD 1 June 25, 2007 NCCCP.

Michael Birrer Ian McNeish New Developments in Biology and Targets of Epithelial Ovarian Cancer.

OEWG Kick-Off Meeting Meg Mooney, MD Chief, Clinical Investigations Branch CTEP, DCTD, NCI – March 24, 2010 CTEP & Cooperative Group Plans for OEWG Implementation:

Gynecologic Oncology Group Gynecologic Oncology Group (GOG) Sharon Stockman, C-CRC The University of Iowa Hospitals Iowa City, IA Chair, GOG Data Management.

PRACTICE PATTERNS OF RADIOTHERAPY IN CERVIX CANCER AMONG MEMBER GROUPS OF THE GYNECOLOGIC CANCER INTERGROUP (GCIG) D GAFFNEY 1, A DU BOIS 2, K NARAYAN.

ACRIN – Ten Excellent Years ACRIN RA Sessions Specificity Sensitivity.

NFBIO: Update on NCI Imaging Activities Daniel C. Sullivan, M.D. Cancer Imaging Program, DCTD, NCI.

Endometrial Committee David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. Director and Dallas Foundation Chair in Gynecologic Oncology Professor of Obstetrics.

Role of the Drug Project Team in Formulating the Initial Development Plan of NCI-IND agents Jeff Moscow, MD IDB, CTEP.

Clinical Trials Design, Development, and Outreach Working Group Richard L. Wahl, M.D. & John Buatti, M.D.

2011 ACRIN Annual Meeting ACRIN Accrual Committee ACRIN 2011 Fall Meeting Reginald F. Munden.

Endometrial Cancer Commitee Minutes Chicago June 3, 2010 David Miller, Ketta Lorusso.

ACRIN Breast Committee Fall Meeting CADe study Etta Pisano, MD Martin Yaffe PhD Elodia Cole, MS Zheng Zhang, PhD ACRIN Breast Committee.

Cancer Liaison Physician Report Sibley Memorial Hospital Cancer Committee Meeting September 14, 2015.

ACRIN EISC Experimental Imaging Sciences Committee (EISC) David Mankoff, MD, PhD Experimental Imaging Sciences Committee Chair Professor of Radiology University.

GCIG Rare Tumor Working Group Prague, CZ, October, 2010 Chair: Isabelle Ray-Coquard Co-Chair: David M. Gershenson.

ACOSOG Sarcoma Committee Chair: Peter W.T. Pisters, MD Vice Chairs: Edward Cheng, MD (Orthopedic Oncology) Robert Maki, MD, PhD (Medical Oncology) Brian.

Clinical and Research Updates in Gynecologic Oncology

Interagency Oncology Task Force (IOTF)

How to Navigate the NCTN and Participate in Imaging Research

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Marie Florescu,

Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD

Oncology Grand Rounds “Potentially Lethal Prostate Cancer:

S1400 OVERVIEW / BACKGROUND

MTCC Organizational Chart

History of TN:Mission Lifeline

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

Protocol for the Treatment of Malignant Inoperable Bowel Obstruction: A Prospective Study of 80 Cases at Grenoble University Hospital Center Guillemette.

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Marie Florescu,

What is ENGOT? Antonio González Martín

Eduardo Bruera, MD, Raul Sala, MD, Odette Spruyt, MD, J

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study Vivian E. von Gruenigen,

OPTN/UNOS Ethics Committee

Gynecologic Cancer Committee Clinical Trial Development

Clinical Trial Development: RA’s Role, OEWG, and IRB Submissions Martha Heckel Protocol Associate, ACRIN Dept. of Protocol Development & Regulatory.

NRG Oncology Biospecimen Bank Report NRG Semiannual meeting

Clinical Trial Development: NRG Processes and NCI Requirements

BDHP Cancer Theme Seminar Haematology Cancers

Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,

Consensus Report of a Joint NCI Thoracic Malignancies Steering Committee: FDA Workshop on Strategies for Integrating Biomarkers into Clinical Development.

Joan L. Walker, M.D. Stephenson Cancer Center University of Oklahoma

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study Vivian E. von Gruenigen,

Presentation transcript:

ACRIN Abdominal Committee ACRIN Gynecologic Committee Fall Meeting 2010 Susanna I Lee, MD, PhD, Chair Massachusetts General Hospital

ACRIN Gynecologic Committee Learning Objectives  Identify imaging technologies that could serve as prognostic biomarkers in targeted treatment of ovarian cancer.  Develop imaging methods that could serve to optimize anatomically and functionally targeted treatment of gynecologic cancer.  Discuss scientific goals and preliminary results of ongoing gynecologic research trials and their relevance to ACRIN’s overall research goals.

ACRIN Gynecologic Committee Committee Members Zheng Zhang Jean Lee

ACRIN Gynecologic Committee NCI Gynecologic Cancer Trials  Cancer Imaging Program  ACRIN  Gynecologic Cancer Program  GOG, SWOG, RTOG  Steering committee  Task forces – Ovary, Uterine corpus, Cervix  Gynecologic Cancer Intergroup